Photodynamic therapy for CIN3
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with CIN3 and want to try photodynamic therapy
- Your cervix has a type 1 or type 2 transformation zone that the doctor can see fully with a colposcope
- The edges of the abnormal area are clearly visible
- A sample from deeper in the cervix (ECC) did not show high-grade changes
- You do not have porphyria or an allergy to red or blue light
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
This study tests a new light-based device to screen for cervical cancer. It is for people who already have abnormal screening results (like high-risk HPV and an abnormal Pap test).
This study tests a new light-based device to screen for cervical cancer. It may help find cancer earlier in people with certain HPV types or abnormal Pap tests.
This trial tests a light-activated therapy (called photodynamic therapy) using a special gel that is put on the skin and then activated with a light to treat moderate to severe acne. It may help people who have not responded well to other treatments.
This study tests a light-based treatment (photodynamic therapy) for cervical precancer called CIN2. It may be an option if you want to avoid surgery and preserve the cervix.
This study tests a special light-based treatment (called HAL-PDT) for early cervical changes (CIN2) that were found on a recent biopsy. The goal is to see if this treatment can safely remove these changes and prevent them from becoming cancer.
Hear when a new Precancerous Cervical Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.